Prostate Cancer - Results from #25680

Accuracy of endorectal magnetic resonance imaging (MRI) and dynamic contrast enhanced-MRI (DCE-MRI) in the preoperative local staging of prostate cancer - Abstract June 12, 2012

Beyond PSA: Are new prostate cancer biomarkers of potential value to New Zealand doctors? - Abstract June 12, 2012

Variability of the urological clinical practice in prostate cancer in Spain - Abstract June 12, 2012

Evaluation of the respiratory prostate motion with four-dimensional computed tomography scan acquisitions using three implanted markers - Abstract June 12, 2012

Increasing the risk of late rectal bleeding after high-dose radiotherapy for prostate cancer: The case of previous abdominal surgery. Results from a prospective trial - Abstract June 12, 2012

Optimization of treatment planning parameters used in tomotherapy for prostate cancer patients - Abstract June 12, 2012

Robotic transrectal ultrasonography during robot-assisted radical prostatectomy - Abstract June 12, 2012

Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases - Abstract June 12, 2012

Active surveillance as a practical strategy to differentiate lethal and non-lethal prostate cancer subtypes - Abstract June 11, 2012

Genitourinary malignancy presenting as an ocular metastasis: A case report and review of the literature - Abstract June 11, 2012

Defining a magnetic resonance scan sequence for permanent seed prostate brachytherapy postimplant assessment - Abstract June 11, 2012

Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growth - Abstract June 11, 2012

Risk assessment of metastatic recurrence in patients with prostate cancer by using the Cancer of the Prostate Risk Assessment score: Results from 2937 European patients - Abstract June 11, 2012

The dose-response of the anal sphincter region - an analysis of data from the MRC RT01 trial - Abstract June 11, 2012

Do we need to obtain consent for penile shortening as a complication of treatment for organ-confined prostate cancer? - Abstract June 11, 2012

Predicting participation in and successful outcome of a penile rehabilitation programme using a phosphodiesterase type 5 inhibitor with a vacuum erection device after radical prostatectomy - Abstract June 11, 2012

Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice - Abstract June 11, 2012

Prostate cancer: Promising biomarkers related to aggressive disease - Abstract June 11, 2012

Improved differentiation between ductal and acinar prostate cancer using three-dimensional histology and biomarkers - Abstract June 11, 2012

Measurement of patient imaging dose for real-time kilovoltage x-ray intrafraction tumour position monitoring in prostate patients - Abstract June 11, 2012

Page 1285 of 1438